VOR insider transaction filings
Vor Biopharma Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-21. Screen VOR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Option exercise/expiry (X): 2,100,000 @ $0.00 · Sale (S): 213 @ $19.75 · Option exercise/expiry (X): 2,100,000 (derivative) @ $5 | EDGAR |
| 2026-07-09 | 4 | ZACCARDELLI DAVID — Director | Grant/award (A): 42,658 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Joustra Wouter — Director | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Levin Andrew David — Director | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Detheux Michel — Director | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Namouni Fouad — Director | Grant/award (A): 56,549 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Cumbo Alexander — Director | Grant/award (A): 56,345 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Beckman Daniella — Director | Grant/award (A): 53,283 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Kalir Erez — Director | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 57,162 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 165,150 @ $15.77 | EDGAR |
| 2026-04-21 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 458,411 @ $16.28 · Sale (S): 171,963 @ $15.77 | EDGAR |
| 2026-04-15 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 530,610 @ $16.15 · Sale (S): 153,735 @ $15.97 · Sale (S): 53,644 @ $16.01 | EDGAR |
| 2026-04-10 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 353,242 @ $16.32 · Sale (S): 130,862 @ $16.91 · Sale (S): 135,201 @ $16.59 · Sale (S): 828 @ $15.75 | EDGAR |
| 2026-04-06 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 258,475 @ $18.23 · Sale (S): 1,525 @ $19.06 · Sale (S): 537,754 @ $16.51 · Sale (S): 44,728 @ $17.31 · Sale (S): 6,775 @ $18.50 | EDGAR |
| 2025-12-19 | 4 | Joustra Wouter — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Levin Andrew David — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 4,625,346 @ $10.81 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Zuraw Qing Che — Chief Development Officer | Disposition to issuer (D): 218,652 (derivative) @ $0 · Grant/award (A): 218,652 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Kress Jean-Paul — CEO and Chairman, Director | Disposition to issuer (D): 4,164,831 (derivative) @ $0 · Grant/award (A): 4,164,831 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Mahatme Sandesh — CFO | Disposition to issuer (D): 694,137 @ $0 · Grant/award (A): 1,388,274 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 87,828 @ $27.10 · Sale (S): 36,483 @ $28.18 · Sale (S): 251,518 @ $25.22 · Sale (S): 24,579 @ $25.12 | EDGAR |
| 2025-10-27 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 76,880 @ $28.01 · Sale (S): 53,345 @ $28.01 · Sale (S): 90,941 @ $28.12 | EDGAR |
| 2025-10-22 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 70,366 @ $29.63 · Sale (S): 13,817 @ $29.63 · Sale (S): 6,553 @ $30.12 · Sale (S): 1,287 @ $30.12 · Sale (S): 25,027 @ $28.11 | EDGAR |
| 2025-10-21 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 24,689 @ $30.22 · Sale (S): 1,028 @ $31 · Sale (S): 11,616 @ $30.05 · Sale (S): 200 @ $30.07 | EDGAR |
| 2025-10-17 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 14,851 @ $31.05 · Sale (S): 48,910 @ $32.05 · Sale (S): 7,894 @ $32.77 · Sale (S): 2,021 @ $30.45 | EDGAR |
| 2025-10-17 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Sale (S): 42,699 @ $30.55 · Sale (S): 8,384 @ $30.55 · Sale (S): 234 @ $31.17 · Sale (S): 46 @ $31.17 · Sale (S): 111,041 @ $29.32 · Sale (S): 21,804 @ $29.32 · +10 more | EDGAR |
| 2025-10-15 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 40,983 @ $30.97 · Sale (S): 19,672 @ $32.36 · Sale (S): 2,334 @ $33.09 · Sale (S): 33,668 @ $30.32 | EDGAR |
| 2025-10-10 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 60,926 @ $33.75 · Sale (S): 14,336 @ $34.34 · Sale (S): 33,842 @ $31.92 · Sale (S): 15,042 @ $32.41 | EDGAR |
| 2025-10-08 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 17,760 @ $36.00 · Sale (S): 34,847 @ $37.12 · Sale (S): 18,156 @ $37.77 · Sale (S): 27,624 @ $33.84 | EDGAR |
| 2025-10-03 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 1,400 @ $39.19 · Sale (S): 4,937 @ $37.21 · Sale (S): 1,513 @ $38.38 · Sale (S): 7,700 @ $39.57 · Sale (S): 13,001 @ $40.13 · Sale (S): 5,300 @ $42.32 · +2 more | EDGAR |
| 2025-09-22 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 10,000,000 (derivative) @ $5 | EDGAR |
| 2025-09-18 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 447,278 @ $1.54 | EDGAR |
| 2025-09-15 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 284,805 @ $1.83 · Sale (S): 300,000 @ $1.75 · Sale (S): 400,000 @ $1.64 | EDGAR |
| 2025-09-10 | 4 | Reed Sarah Burgess — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 464,421 @ $1.99 · Sale (S): 449,226 @ $2.00 · Sale (S): 350,000 @ $1.82 | EDGAR |
| 2025-09-10 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 554,612 @ $2.00 · Sale (S): 453,016 @ $1.93 · Sale (S): 400,000 @ $1.97 | EDGAR |
| 2025-08-29 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 611,647 @ $2.01 · Sale (S): 806,351 @ $2.01 | EDGAR |
| 2025-08-27 | 4 | Reprogrammed Interchange LLC — 10% owner Hoffman Reid — 10% owner | Sale (S): 387,346 @ $2.12 · Sale (S): 284,190 @ $2.08 | EDGAR |
| 2025-07-30 | 4 | Zuraw Qing Che — Chief Development Officer | Grant/award (A): 937,080 @ $0 · Grant/award (A): 4,373,040 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Detheux Michel — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Cumbo Alexander — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Mahatme Sandesh — CFO | Grant/award (A): 13,882,750 @ $0 | EDGAR |
| 2025-06-27 | 4 | Kress Jean-Paul — CEO and Chairman, Director | Grant/award (A): 83,296,638 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Namouni Fouad — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Resnick Joshua — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Lundberg Sven Ante — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Lubner David Charles — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Beckman Daniella — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vor Biopharma Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →